Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

RBMY1J Activators

RBMY1J Activators would refer to a group of molecules with the capacity to enhance the biological activity of this protein. These activators would likely interact with RBMY1J at specific sites, which could be directly involved with the protein's active domain, or at distinct regulatory domains, affecting the protein's function allosterically. The diversity in chemical structure among RBMY1J Activators would be considerable, potentially encompassing small organic compounds, modified peptides, or other specialized molecules. The structural diversity would be aligned with the necessity to engage with the specific structural nuances of RBMY1J, ensuring an effective and selective activation.

In the theoretical framework of developing RBMY1J Activators, the process would begin with an in-depth structural analysis of the RBMY1J protein. Determining the structure, possibly through X-ray crystallography, cryo-electron microscopy, or NMR spectroscopy, would yield critical insights into the protein's configuration and the particular sites amenable to activation. Computational drug design techniques, such as molecular docking and virtual screening, would be instrumental in the initial identification of molecular structures capable of interacting with RBMY1J. Following in silico predictions, potential activators would be synthesized and their effects on RBMY1J activity would be assessed through a series of biochemical assays. It is likely that a high-throughput screening approach would be employed to sift through large libraries of compounds to find those with promising activating effects. Successful hits would then undergo a process of chemical optimization, guided by structure-activity relationship (SAR) analysis, to fine-tune the potency, selectivity, and stability of these compounds with respect to their interaction with RBMY1J. The iterative cycle of design, synthesis, and testing would continue until compounds that proficiently modulate RBMY1J activity are obtained, providing valuable insights into the protein's role and the fundamental biochemical pathways in which it operates.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ketoconazole

65277-42-1sc-200496
sc-200496A
50 mg
500 mg
$63.00
$265.00
21
(1)

As an inhibitor of steroid biosynthesis, ketoconazole might indirectly affect the hormonal regulation of spermatogenic genes.

Finasteride

98319-26-7sc-203954
50 mg
$105.00
3
(1)

This compound inhibits the conversion of testosterone to DHT and could alter gene expression patterns in the testis.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

TSA is a histone deacetylase inhibitor that can change chromatin structure and potentially impact gene expression.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

A DNA methyltransferase inhibitor that can alter epigenetic marks and potentially affect gene expression in the testis.

Flutamide

13311-84-7sc-204757
sc-204757A
sc-204757D
sc-204757B
sc-204757C
1 g
5 g
25 g
500 g
1 kg
$47.00
$156.00
$171.00
$525.00
$941.00
4
(1)

An antiandrogen that could impact androgen signaling and thereby influence the expression of androgen-regulated genes.

Vinclozolin

50471-44-8sc-251425
250 mg
$23.00
1
(1)

A fungicide known to act as an antiandrogen, possibly affecting the hormonal regulation of testicular gene expression.

Ethynyl Estradiol

57-63-6sc-205318
sc-205318A
100 mg
500 mg
$20.00
$29.00
3
(1)

A synthetic estrogen that could potentially disrupt normal endocrine signaling and affect gene expression in reproductive tissues.